Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma (Q34104147)

31 July 2017

Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma (English)

1 reference

31 July 2017

5

Masato Nishimura

1 reference

31 July 2017

20

Anil K Sood

1 reference

31 July 2017

Whitney A Spannuth

1

1 reference

31 July 2017

Lingegowda S Mangala

2

1 reference

31 July 2017

Rebecca L Stone

3

1 reference

31 July 2017

Amy R Carroll

4

1 reference

31 July 2017

Mian M K Shahzad

6

1 reference

31 July 2017

Sun-Joo Lee

7

1 reference

31 July 2017

Myrthala Moreno-Smith

8

1 reference

31 July 2017

Alpa M Nick

9

1 reference

31 July 2017

Ren Liu

10

1 reference

31 July 2017

Nicholas B Jennings

11

1 reference

31 July 2017

Yvonne G Lin

12

1 reference

31 July 2017

William M Merritt

13

1 reference

31 July 2017

Robert L Coleman

14

1 reference

31 July 2017

Pablo E Vivas-Mejia

15

1 reference

31 July 2017

Yue Zhou

16

1 reference

31 July 2017

Valery Krasnoperov

17

1 reference

31 July 2017

Gabriel Lopez-Berestein

18

1 reference

31 July 2017

Parkash S Gill

19

1 reference

31 July 2017

3 August 2010

1 reference

Molecular Cancer Therapeutics

31 July 2017

1 reference

31 July 2017

9

1 reference

31 July 2017

2377-2388

1 reference

31 July 2017

8

1 reference

Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Enhancing mTOR-targeted cancer therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

EPHB4 and survival of colorectal cancer patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Receptor tyrosine kinase EphB4 is a survival factor in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Stress hormone-mediated invasion of ovarian cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Up-regulation of EphB4 in mesothelioma and its biological significance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

EphB4 expression and biological significance in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Eph receptor signalling casts a wide net on cell behaviour

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Inhibition of tumor growth and angiogenesis by soluble EphB4.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Molecular determinants of ovarian cancer plasticity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2933364

Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20682653

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cancer statistics, 2009

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.3322/CAAC.20006

Identifiers

DOI

10.1158/1535-7163.MCT-10-0200

1 reference

31 July 2017

1 reference

31 July 2017

1 reference